Reason for request
Inclusion on the list of medicines reimbursed by National Insurance and approved for use by hospitals.
Clinical Benefit
| Insufficient |
The actual benefit of LERCAPRESS 10 mg/10 mg is insufficient in view of the available clinical data: this data is insufficient to assess its value for the management of hypertensive patients. |
| Substantial |
|
Clinical Added Value
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
aU0qBkbsC4vFSaHX
